The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Clinical ancillary management: Reducing risk and improving readiness in global trials

On-demand webinar

Ancillary supplies are essential to protocol execution, but inconsistent supply, limited site readiness, or regulatory missteps can compromise timelines. As clinical trial protocols grow more specialized and geographically dispersed, biotech and biopharma companies are reevaluating how they manage ancillary sourcing, oversight, and delivery.

In this webinar, Molly Isermann, Senior Manager of Product Management, Clinical Ancillary Management at Thermo Fisher Scientific, shares how our clinical ancillary management (CAM) services support patient-first readiness, reduce supply-related delays, and adapt to the evolving needs of global studies. Molly has worked at Thermo Fisher for over 15 years, supporting customers across various industries with their laboratory and clinical supply, capital equipment, and service needs. As part of the clinical ancillary management team, she ensures customers receive the highest standard of CAM product and service offerings for their clinical trials.

Highlights from this webinar include:

  • How early planning and flexible supply models help ensure site readiness
  • Why centralized CAM oversight supports risk mitigation across regions
  • Strategies for adapting supply models to trial complexity
  • How regulatory alignment and supplier performance affect delivery reliability
  • Comprehensive overview of Thermo Fisher’s CAM services
  • Flexible CAM supply models and tiered services for personalized needs 
Speaker
Molly Isermann
Senior Manager of Product Management, Clinical Ancillary Management
Pharma Services, Thermo Fisher Scientific